1. FcγRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck

   • Rodney J. Taylor
   • Siaw-Lin Chan
   • Scott E. Strome

   Original Article 01 November 2008 Pages: 997 - 1006

   

2. Intratumoral interferon-α gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation

   • Hidehiko Hara
   • Akihiko Kobayashi
   • Kazunori Aoki

   Original Article 08 November 2008 Pages: 1007 - 1021

   

3. A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells

   • Ling-Yuan Kong
   • Jun Wei
   • Amy B. Heimberger

   Original Article 11 November 2008 Pages: 1023 - 1032

   

4. The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells

   • Christine Galustian
   • Brendan Meyer
   • Angus G. Dalgleish

   Original Article 14 November 2008 Pages: 1033 - 1045

   

5. Reduced levels of recent thymic emigrants in acute myeloid leukemia patients

   • Yangqiu Li
   • Qingsong Yin
   • Grzegorz K. Przybylski

   Original Article 19 November 2008 Pages: 1047 - 1055

   

6. Localized expression of GITR-L in the tumor microenvironment promotes CD8⁺ T cell dependent anti-tumor immunity

   • John S. Cho
   • Jeffrey V. Hsu
   • Sherie L. Morrison

   Original Article 19 November 2008 Pages: 1057 - 1069

   

7. Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival

   • Tatiana M. Garcia-Bates
   • Scott A. Peslak
   • Richard P. Phipps

   Original Article 19 November 2008 Pages: 1071 - 1083

   

8. Prognostic significance of tumor iNOS and COX-2 in stage III malignant cutaneous melanoma

   • C. Christian Johansson
   • Suzanne Egyházi
   • Rolf Kiessling

   Original Article 28 November 2008 Pages: 1085 - 1094

   

9. Phenotypic and functional alterations of Vγ2Vδ2 T cell subsets in patients with active nasopharyngeal carcinoma

   • Kia Joo Puan
   • John Seng Hooi Low
   • Kam M. Hui

   Original Article 30 November 2008 Pages: 1095 - 1107

   

10. Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells

    • Danita H. Schuurhuis
    • W. Joost Lesterhuis
    • Gosse J. Adema

    Short Communication 19 November 2008 Pages: 1109 - 1115

    

11. Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma

    • Y. Diaz
    • A. Gonzalez
    • E. Montero

    Short Communication 10 December 2008 Pages: 1117 - 1128

    

12. Immunotherapy: from basic research to clinical applications

    • Christina Stoeckle
    • Anne-Kathrin Gleske

    Meeting Report 27 June 2008 Pages: 1129 - 1136

13. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy

    • Vincent Flacher
    • Florian Sparber
    • Patrizia Stoitzner

    Symposium Paper Open access 02 August 2008 Pages: 1137 - 1147

    

14. Innate signaling by the C-type lectin DC-SIGN dictates immune responses

    • Jeroen den Dunnen
    • Sonja I. Gringhuis
    • Teunis B. H. Geijtenbeek

    Symposium Paper Open access 08 November 2008 Pages: 1149 - 1157

    

15. Modified peptides in anti-cancer vaccines: are we eventually improving anti-tumour immunity?

    • Manuela Iero
    • Paola Filipazzi
    • Licia Rivoltini

    Symposium Paper 08 November 2008 Pages: 1159 - 1167

    

16. Vaccination strategies in patients with renal cell carcinoma

    • Anne Marie Asemissen
    • Peter Brossart

    Symposium Paper 10 April 2009 Pages: 1169 - 1174